Javascript must be enabled to continue!
Abstract 1350: Macrophages induce COX-2 expression in breast cancer cells: Role of IL-1β dependent signal transduction pathways
View through CrossRef
Abstract
Macrophages are a major component of the inflammatory infiltrate observed in many tumors including carcinoma of the breast. Evidence suggests that tumor associated macrophages (TAMs) are a part of an inflammatory “loop” that promotes tumor progression. In the breast, the presence of high numbers of TAMs is associated with a poor prognosis. However, the mechanisms underlying the interactions between TAMs and breast cancer cells are not clearly understood. In this regard, cyclooxygenase-2 (COX-2) is over expressed in approximately 40% of breast cancers, and is associated with a poor prognosis. COX-2 derived prostaglandin E2 (PGE2) promotes the growth and metastasis of breast cancers. To determine whether TAMs regulate COX-2 expression in breast cancer cells, PMA-treated THP-1 cells grown on porous inserts were co-cultured with HCC1954 breast cancer cells. The presence of THP-1 cells led to increased COX-2 expression in the breast cells and elevated levels of PGE2 in conditioned media. Similar results were observed when THP-1 cells were incubated with HCC1937 cells and when peripheral blood-derived mononuclear cells were incubated with HCC1954 cells. To identify potential paracrine factors that mediated COX-2 induction in breast cancer cells, levels of pro-inflammatory cytokines in THP-1/HCC1954 co-culture conditioned media were measured. The levels of IL-1β rose rapidly in co-culture conditioned media. Moreover, the expression of IL-1β in both breast cancer cells and macrophages was increased as a result of co-culture. This increased expression was blocked in both cells by IL-1 receptor antagonist (IL-1ra) suggesting an autocrine loop. Importantly, the addition of IL-1ra or IL-1β neutralizing antibody blocked the induction of COX-2 in HCC1954 cells. These data suggest that IL-1β is a major mediator of COX-2 induction. Co-culture conditioned media triggered production of reactive oxygen species (ROS) in naïve HCC1954 cells. Blocking ROS production by DPI (a NADPH oxidase inhibitor) or knocking down the expression of p67 subunit of the NADPH oxidase complex led to inhibition of COX-2 induction in HCC1954 cells. ROS production in HCC1954 cells triggered activation of Src kinase, and subsequently the downstream MAP kinases (ERK, p38, and JNK). Blocking the activity of Src or MAP kinases, utilizing specific inhibitors or siRNA, attenuated COX-2 induction. In summary, we identified that IL-1β was a major mediator of COX-2 induction in HCC1954 cells co-cultured with THP-1 macrophages. We also showed that co-culture induced COX-2 expression was a consequence of IL-1β dependent ROS→Src→MAP kinases signaling. These findings provide new insights into the mechanisms of interactions between TAMs and breast cancer cells and potential intervention targets in TAM-positive breast cancers.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 1350.
American Association for Cancer Research (AACR)
Title: Abstract 1350: Macrophages induce COX-2 expression in breast cancer cells: Role of IL-1β dependent signal transduction pathways
Description:
Abstract
Macrophages are a major component of the inflammatory infiltrate observed in many tumors including carcinoma of the breast.
Evidence suggests that tumor associated macrophages (TAMs) are a part of an inflammatory “loop” that promotes tumor progression.
In the breast, the presence of high numbers of TAMs is associated with a poor prognosis.
However, the mechanisms underlying the interactions between TAMs and breast cancer cells are not clearly understood.
In this regard, cyclooxygenase-2 (COX-2) is over expressed in approximately 40% of breast cancers, and is associated with a poor prognosis.
COX-2 derived prostaglandin E2 (PGE2) promotes the growth and metastasis of breast cancers.
To determine whether TAMs regulate COX-2 expression in breast cancer cells, PMA-treated THP-1 cells grown on porous inserts were co-cultured with HCC1954 breast cancer cells.
The presence of THP-1 cells led to increased COX-2 expression in the breast cells and elevated levels of PGE2 in conditioned media.
Similar results were observed when THP-1 cells were incubated with HCC1937 cells and when peripheral blood-derived mononuclear cells were incubated with HCC1954 cells.
To identify potential paracrine factors that mediated COX-2 induction in breast cancer cells, levels of pro-inflammatory cytokines in THP-1/HCC1954 co-culture conditioned media were measured.
The levels of IL-1β rose rapidly in co-culture conditioned media.
Moreover, the expression of IL-1β in both breast cancer cells and macrophages was increased as a result of co-culture.
This increased expression was blocked in both cells by IL-1 receptor antagonist (IL-1ra) suggesting an autocrine loop.
Importantly, the addition of IL-1ra or IL-1β neutralizing antibody blocked the induction of COX-2 in HCC1954 cells.
These data suggest that IL-1β is a major mediator of COX-2 induction.
Co-culture conditioned media triggered production of reactive oxygen species (ROS) in naïve HCC1954 cells.
Blocking ROS production by DPI (a NADPH oxidase inhibitor) or knocking down the expression of p67 subunit of the NADPH oxidase complex led to inhibition of COX-2 induction in HCC1954 cells.
ROS production in HCC1954 cells triggered activation of Src kinase, and subsequently the downstream MAP kinases (ERK, p38, and JNK).
Blocking the activity of Src or MAP kinases, utilizing specific inhibitors or siRNA, attenuated COX-2 induction.
In summary, we identified that IL-1β was a major mediator of COX-2 induction in HCC1954 cells co-cultured with THP-1 macrophages.
We also showed that co-culture induced COX-2 expression was a consequence of IL-1β dependent ROS→Src→MAP kinases signaling.
These findings provide new insights into the mechanisms of interactions between TAMs and breast cancer cells and potential intervention targets in TAM-positive breast cancers.
Citation Format: {Authors}.
{Abstract title} [abstract].
In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 1350.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract
IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Effect of type lll collagen coating of electrospun scaffolds on breast cancer cell apoptosis
Effect of type lll collagen coating of electrospun scaffolds on breast cancer cell apoptosis
Breast cancer arises from the epithelial or the connective tissue components of the breast. Breast cancer is the most commonly diagnosed cancer in women, with about half a million ...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Abstract 3432: Role of M2 macrophages in chemoresistance about the tumor microenvironment of epithelial ovarian cancer
Abstract 3432: Role of M2 macrophages in chemoresistance about the tumor microenvironment of epithelial ovarian cancer
Abstract
OBJECTIVE:
One of the hallmark characteristics of ovarian cancer is the development of resistance to chemotherap...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Abstract 4150: TNFα and TGFβ1 secreted by macrophages enhance breast cancer cell migration dynamics via the induction of NF-κB dependent MMP-1 expression
Abstract 4150: TNFα and TGFβ1 secreted by macrophages enhance breast cancer cell migration dynamics via the induction of NF-κB dependent MMP-1 expression
Abstract
Metastasis, which is a major cause of cancer death, depends on cancer cell's ability to migrate through the dense extracellular matrix (ECM) within the soli...
PO-285 A review of effects of exercise on the quality of life in breast cancer survivors
PO-285 A review of effects of exercise on the quality of life in breast cancer survivors
Objective Breast cancer is one of the most common malignant tumors in women.The number of women diagnosed with breast cancer each year is also increasing.It is also the leading cau...

